Trials / Sponsors / Società Italiana Talassemie ed Emoglobinopatie
Società Italiana Talassemie ed Emoglobinopatie
Academic / Other · 8 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | STUDY INCIDENCE AND CHARACTERISTICS OF MALIGNANT NEOPLASIES IN PATIENTS WITH HEMOGLOBINOPATHY FOLLOWED IN ITAL Malignacy, Hemoglobinopathie | — | 2022-02-01 |
| Active Not Recruiting | Monitoring of Anti-SARS-CoV-2 (COVID 19) and Encapsulated Vaccination Patients With Thalassemic and Falcemic S SARS-CoV-2 Infection, Thalasemmie, SCD | — | 2022-01-01 |
| Recruiting | Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19 Haemoglobinopathies | — | 2020-03-31 |
| Completed | Transfusion Treatment in Patients With SCD Anemia, Sickle Cell | — | 2016-07-01 |
| Completed | A Nationwide Italian Survey on Asplenia Splenectomy; Status | — | 2016-03-01 |
| Completed | Hydroxyurea in the Treatment of Sickle Cell Disease Sickle Cell Disease | — | 2015-11-01 |
| Completed | Hepatitis C Virus Infection in Patients With Hemoglobinopathies Hepatitis C, Chronic, Hemoglobinopathies | — | 2015-03-01 |
| Completed | Vitamin D and Bisphosphonates in the Treatment of Sickle Cell Disease Sickle Cells Disease | — | 2010-01-01 |